Navigation Links
ImQuest BioSciences and Arisyn Therapeutics Announce Strategic Partnership to Develop Infectious Disease and Cancer Drugs
Date:4/29/2009

FREDERICK, Md., April 29 /PRNewswire/ -- ImQuest BioSciences and Arisyn Therapeutics jointly announced today that they have entered into a strategic drug development partnership to provide support necessary to develop Arisyn's portfolio of novel inhibitors for the treatment of infectious disease and cancer. Arisyn has recently announced its acquisition of a series of inhibitors with demonstrated preclinical efficacy against HIV, HCV, HTLV-I, influenza virus, herpes viruses and cancer. These inhibitors were originally discovered and developed by The Proctor & Gamble Company. Lead molecules from the portfolio have already been evaluated in Phase 1 human clinical trials for the treatment of HIV and cancer, and an IND-application has been prepared for submission to the FDA to initiate trials for HCV therapy.

"The Arisyn compounds represent an entirely new treatment paradigm by effectively suppressing the ability of the HIV or HCV-infected cells to act as the factories of progeny virus production," stated Robert W. Buckheit, Jr., Ph.D., Director of Research and Development for Arisyn and President and Chief Scientific Officer of ImQuest BioSciences. "The compounds have proven efficacy and safety in preclinical studies and their successful development will be of immense benefit to the millions of individuals living with HIV and HCV infection."

ImQuest BioSciences, a Contract Research service provider specializing in the discovery and development of anti-infective and anti-cancer agents, will provide all required support to initiate human clinical trials with lead products ATI-0312 for HIV and ATI-0810 for HCV and will initiate mechanistic studies to define the unique virus transcription inhibitory mechanism of action of the class of inhibitors. ImQuest will also lead Arisyn's efforts to develop next generation inhibitors from structure activity relationship studies and target-based drug design programs.

"This p
'/>"/>

SOURCE ImQuest Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ImQuest Presentation at Keystone Symposium Focuses on Advancements in Their Cancer Research and Development Program
2. ImQuest Presents Data on the Anti-Hepatitis B Virus Activity of Pyrimidinediones at the 13th ISVHLD Meeting in Washington D.C.
3. ImQuest Presentations at CROI Report Significant Advances in Therapeutic and Microbicide Product Development Programs
4. ImQuest Presents IND-Enabling Safety Pharmacology and Pharmacokinetic Data for the Therapeutic HIV Compound IQP-0410 at Conference on Retroviruses and Opportunistic Infections
5. ImQuest Receives $6.4 M Five Year Award from NIH to Develop Long-Lasting Combination Topical Microbicides To Prevent HIV Transmission
6. ImQuest Awarded SBIR Grant to Define the Mechanism of Action of Their Lead Anti-HIV Therapeutic Compound IQP-0410
7. LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record
8. Former GE Healthcare Director, Per Foss Appointed CEO for HUNT Biosciences
9. Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast
10. Cell Biosciences Launches Next-Generation Protein Characterization System
11. Cell Biosciences Announces Publication in Nature Medicine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...all/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobals...atithassubmittedaMAAtotheEuropeanMedicinesAgencyfo...herapyindevelopment,forthetreatmentofType1Gaucherd...lucerasealfathathasbeensubmitted,withprevious,subm...globalsupplyshortageofthecurrentlyapprovedandmarke...
(Date:11/24/2009)...Customers with Partners Validated to Process and A... , Ottawa, ON (PRWEB) Nov...r of products for biological sample collection, st...ew global partner program. The program offers sign...munity and is designed to help partners scale and ...
(Date:11/23/2009)...rigami very high-tech origami. , Researchers at ...que for fabricating three-dimensional, single-crys...ling photolithography and a self-folding process d...y a few microns thick, offer mechanical bendabilit...same material. , "This is a completely different ...
(Date:11/23/2009)...rstCall/-YMBioSciencesInc.(NYSEAmex: YMI ;TSX:YM),...esandadvancesadiverseportfolioofpromisingcancer-re...ortedthatCytopia(ASX:CYT)hascommencedenrollmentofa...nisteredJAK1/JAK2inhibitor.Thetrialisbeingconducte...eCytopiaintoYMhasbeenpreviouslyannouncedandispendi...
Breaking Biology Technology:Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4
...arter Highlights:, -- Record revenues of $82.0 mi... quarter -- Non-re...n-GAAP earnings per share of $0.23, a 130% increas...arnings per share, -- Operating cash flow of $24.3...nch of four new food and beverage products and one...
...nnounces second office in Mumbai, WILMINGTON, N.C...ed the appointment of Philip Mathew, M.D., as dire...,s Phase II-IV operations and,expansion in India.,... PPD,s drug development,business on the Indian sub...nd patient recruitment for key therapeutic areas. ...
..., Calif., Dec. 12 Beckman Coulter,Inc. (NYSE: BE... and,automate complex biomedical testing, announce...officer, president, and director of AMN,Healthcare...the board of,directors of Beckman Coulter, effecti...gi-bin/prnh/20031202/BECLOGO ), "Susan is a high...
Other Biology Technology:Martek Announces Fourth Quarter and FY 2007 Financial Results 2Martek Announces Fourth Quarter and FY 2007 Financial Results 3Martek Announces Fourth Quarter and FY 2007 Financial Results 4Martek Announces Fourth Quarter and FY 2007 Financial Results 5Martek Announces Fourth Quarter and FY 2007 Financial Results 6Martek Announces Fourth Quarter and FY 2007 Financial Results 7Martek Announces Fourth Quarter and FY 2007 Financial Results 8Martek Announces Fourth Quarter and FY 2007 Financial Results 9Martek Announces Fourth Quarter and FY 2007 Financial Results 10Martek Announces Fourth Quarter and FY 2007 Financial Results 11Martek Announces Fourth Quarter and FY 2007 Financial Results 12Martek Announces Fourth Quarter and FY 2007 Financial Results 13Martek Announces Fourth Quarter and FY 2007 Financial Results 14Martek Announces Fourth Quarter and FY 2007 Financial Results 15Mathew to Lead PPD Drug Development Operations and Expansion in India 2Mathew to Lead PPD Drug Development Operations and Expansion in India 3Beckman Coulter Elects AMN Healthcare Executive to Board of Directors 2
(Date:11/24/2009)... Cambridge, Md. (November 24, 2009) New research ...ic river ecosystems reveals predictable temporal p...e communities as markers for monitoring climate ch...is week in the Proceedings of the National Academ... communities in the six rivers shifted synchronous...
(Date:11/23/2009)..., TORONTO, November 23, 2009 - The time of day ma...ing to a new paper produced by a research team led...nto Scarborough,s vice-principal for research and ...iology at the St. George campus. , Capitalizin...he poplar tree, the research team examined how pop...
(Date:11/23/2009)..., AMES, Iowa - The only swine vaccine available f...ne herd infected with the virus. The vaccination m...ne herd diagnosed with the pandemic flu., Iowa S... science, developed the vaccine this summer and ha...s in Iowa, Kansas and Illinois for several weeks.,...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Time of day matters to thirsty trees, U of T researcher discovers 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Doctors Stand Together Against Government Takeover of Healthcare on Sept 10th in DC 56566 1Simbionix USA Corporation Announces the Appointment of Mr Paul Jensen as General Manager for its Growing eLearning and Content Business 13943 1Simbionix USA Corporation Announces the Appointment of Mr Paul Jensen as General Manager for its Growing eLearning and Content Business 13943 2Champions Biotechnology to Present at Rodman 26 Renshaws Eleventh Annual Healthcare Conference 13941 1Champions Biotechnology to Present at Rodman 26 Renshaws Eleventh Annual Healthcare Conference 13941 2Champions Biotechnology to Present at Rodman 26 Renshaws Eleventh Annual Healthcare Conference 13941 3
...er therapies often succeed at initially eliminatin...roliferating cells, but are eventually thwarted be...ultiple-drug-resistant tumor cells, called cancer ...disease recurrence and eventual metastasis. Now, r...rgh School of Medicine suggests that for chemother...
...e of human and animal infections, Staphylococcus a...ces and dodge antibiotics by climbing into our cel...arch in the online open access journal BMC Genomic...n lung cells for up to two weeks. , A team of 12 r...tzerland and the Institute of Food Research, Norwi...
...are drinking too much water, including sports drin...e individuals engaging in prolonged types of endur...intoxication, say international experts who study ...des marathons, triathlons, and long distance cycli...duced hyponatremia (EAH), could be prevented if on...
Other Biology News:Cancer stem cells similar to normal stem cells can thwart anti-cancer agents 2Staphylococcus aureus hides out in cells 2Runners -- Let thirst be your guide 2Runners -- Let thirst be your guide 3Runners -- Let thirst be your guide 4
...t not structural information the AXIMA-LNR linear ...high throughput QA/QC applications and for high pe...lude oligonucleotide QA/QC, SNP analysis, protein ...d polymer analysis, with the ability to run up to ...
RAOEC (R304-05) from European Collection of Cell Cultures (ECACC)
...modular instrument which can be used for a variety...lar, Transducer & Multi-channel Isolated Amplifica...L900D) forms the heart of every NeuroLog System. ...ing within the case allows signals to be passed be...
Mouse Anti-Drosophila Yan Drosophila protein Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Biology Products: